16
Participants
Start Date
April 30, 2016
Primary Completion Date
October 31, 2018
Study Completion Date
October 31, 2018
Protocol for rapid FiO2 optimization
"We plan to test a protocol for FiO2 optimization for mechanically ventilated post-cardiac arrest subjects, with a therapeutic goal of partial pressure of arterial oxygen (PaO2) of 60-99 mmHg, based on the PaO2 range that was associated with the lowest risk of poor outcome in our previously published work. We also use PaO2 (measured by arterial blood gas \[ABG\] analysis) as the ultimate goal rather than arterial oxygen saturation (SaO2) measured by pulse oximetry because an SaO2 value \<100% on pulse oximetry monitoring does not always exclude supranormal PaO2. The protocol in this application begins with very rapid reduction of FiO2 as much as possible according to SaO2 values, and when FiO2 is maximally reduced by SaO2 an ABG is measured, followed by finer adjustment of FiO2 to achieve a PaO2 60-99 mmHg. The protocol not only prescribes each downward titration of FiO2 but it also includes detailed limbs for upward titration of FiO2 to account for potential overshoot in FiO2 reduction."
Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center, Philadelphia
University of Mississippi Medical Center, Jackson
Indiana University/ Methodist Hospital, Indianapolis
Beth Israel Deaconess Medical Center, Boston
Cooper University Hospital, Camden
National Heart, Lung, and Blood Institute (NHLBI)
NIH
The Cooper Health System
OTHER